1. Home
  2. Research
  3. Research Groups
  4. Lung cancer translational research

Lung cancer translational research

The Lung Cancer Translational Research Group (GITCaP) is dedicated to the research and treatment of thoracic tumors, with a multidisciplinary team of oncologists, surgeons, pathologists, radiologists, pulmonologists and other specialists. Their lines of research focus on identifying predictive markers of treatment efficacy and improving patient survival and quality of life. In addition, they collaborate in clinical trials and projects on microbiota, blood biomarkers, cancer in non-smokers and the impact of radon. They also investigate the use of artificial intelligence in radiology and the promotion of physical exercise to reduce inflammation.

Search for publications

Only original articles, editorials, guidelines.

  • Moreno A, Fernandez-Ibanez R, Del Campo S, Perez-Elias MJ, Casado JL, Garcia M, Velez M, Vivancos MJ, Moreno S.

    Long-Acting Cabotegravir and Rilpivirine in Patients With HIV With Solid Organ Transplantation: A Case Series.

    Open forum infectious diseases . 12(8): .

    [doi:10.1093/ofid/ofaf470]

  • Lee JM, Pujol JL, Zhang J, Leonov O, Tsuboi M, Kim ES, Ng C, Moreno-Mata N, Cummings A, Hacibekiroglu I, Sehitogullari A, Veeramachaneni N, Spillane C, Duan J, Bossen C, Savchenko A, Lobetti-Bodoni C, Mok T, Garrido P.

    CANOPY-N: A Phase 2 Study of Canakinumab or Pembrolizumab, Alone or in Combination, as Neoadjuvant Therapy in Patients With Resectable, Stage IB-IIIA NSCLC.

    Jto Clinical And Research Reports . 6(8): 100859-100859.

    [doi:10.1016/j.jtocrr.2025.100859]

  • Zhou C, Novello S, Garrido P, Dooms C, Alatorre-Alexander J, Reinmuth N, Worthy G, Cocks K, Williams J, Han H, Uh MK, Payakachat N, Gilligan AM, Goto K.

    Patient-Reported Outcomes From LIBRETTO-431: First-Line Selpercatinib Versus Chemotherapy With Pembrolizumab in RET Fusion-Positive NSCLC.

    Jto Clinical And Research Reports . 6(7): 100814-100814.

    [doi:10.1016/j.jtocrr.2025.100814]

  • García-Pardo M, García de Herreros M, Auclin E, Ferriol-Galmes M, Laguna JC, Gorría T, Caravaca G, Sart J, Albarrán-Artahona V, López-Castro R, Teixidó C, Castellano G, Martínez Bedmar A, Arcocha A, Alcolea L, Jiménez M, Bernabeu M, Delgado-Cano D, Navarro A, Prat A, Reguart N, Elio J, Garrido P, Leighl NB, Besse B, Mezquita L.

    Frequency of driver oncogenic alterations in NSCLC and estimated indoor radon exposure in Europe (RADON EUROPE study).

    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY . 17: .

    [doi:10.1177/17588359251351449]

  • Busch F, Hoffmann L, Xu L, Zhang LJ, Hu B, García-Juárez I, Toapanta-Yanchapaxi LN, Gorelik N, Gorelik V, Rodriguez-Granillo GA, Ferrarotti C, Cuong NN, Thi CAP, Tuncel M, Kaya G, Solis-Barquero SM, Mendez Avila MC, Ivanova NG, Kitamura FC, Hayama KYI, Puntunet Bates ML, Torres PI, Ortiz-Prado E, Izquierdo-Condoy JS, Schwarz GM, Hofstaetter JG, Hide M, Takeda K, Peric B, Pilko G, Thulesius HO, Lindow T, Kolawole IK, Olatoke SA, Grzybowski A, Corlateanu A, Iaconi OS, Li T, Domitrz I, Kepczynska K, Mihalcin M, Fašaneková L, Zatonski T, Fulek K, Molnár A, Maihoub S, da Silva Gama ZA, Saba L, Sountoulides P, Makowski MR, Aerts HJWL, Adams LC, Bressem KK, Navarro ÁA, Águas C, Aineseder M, Alomar M, Al Sliman R, Anand G, Angkurawaranon S, Aoki S, Arkoh S, Ashraf G, Astri Y, Bakhshi S, Bayramov NY, Billis A, Bitencourt AGV, Bolejko A, Bollas Becerra AJ, Bwambale J, Capela A, Cau R, Chacon-Acevedo KR, Chaunzwa TL, Chojniak R, Clements W, Cuocolo R, Dahlblom V, Sousa KM, Villarrubia JE, Desai VB, Dhakal AK, Dignum V, Andrade RGF, Ferraioli G, Ganguly S, Garg H, Savevska CG, Radovikj MG, Gkartzoni A, Gorospe L, Griffin I, Hadamitzky M, Ndahiro MH, Hering A, Hochhegger B, Huseynova MR, Ishida F, Jha N, Jiang L, Kader R, Kavnoudias H, Klein C, Kolostoumpis G, Koshy A, Kruger NA, Löser A, Lucijanic M, Mantziari D, Margue G, McFadden S, Miyake M, Morakote W, Ngabonziza I, Nguyen TT, Niehues SM, Nortje M, Palaian S, Pentara NV, de Almeida RPP, Poma G, Purwoko M, Pyrgidis N, Rafailidis V, Rainey C, Ribeiro JC, Agudelo NR, Sado K, Saidman JM, Saturno-Hernandez PJ, Suryadevara V, Schulz GB, Soric E, Soto-Pérez-Olivares J, Stanzione A, Struck JP, Takaoka H, Tanioka S, Huyen TTM, Truhn D, van Dijk EHC, van Wijngaarden P, Wang YC, Weidlich M, Zhang S.

    Multinational Attitudes Toward AI in Health Care and Diagnostics Among Hospital Patients.

    Jama Network Open . 8(6): .

    [doi:10.1001/jamanetworkopen.2025.14452]

  • Fra S, Muñoz-Molina GM, Cano JR, Cabañero A, Caballero U, Cobo J, Monopoli D, Mentado B, Moreno N.

    Innovative posterior chest wall reconstruction with vertebra-fixed custom-made prosthesis.

    Jtcvs Techniques . 31: 199-202.

    [doi:10.1016/j.xjtc.2025.03.025]

  • Chamorro-Pérez J, Lage Y, Albarrán-Fernández V, Rosero-Rodríguez DI, Agudo P, Martínez-Vives P, Olmedo ME, Gómez-Rueda A, García-Pardo M, Garrido-López P.

    Nonbacterial Thrombotic Endocarditis (NBTE) Treated With Crizotinib in Lung Adenocarcinoma Harboring ROS-1 Rearrangement: Two Case Report and Review of Literature.

    CLINICAL LUNG CANCER . 26(4): .

    [doi:10.1016/j.cllc.2025.02.005]

  • Mittal A, Everest L, Patel D, Zhan LJ, Brown MC, Zaeimi F, Schmid S, Khan K, Dietrich K, Balaratnam K, de Santayana MGP, Eng L, Sacher AG, Shepherd FA, Leighl NB, Cho J, De Perrot M, Liu G, Bradbury P.

    Health Utility and Symptom Scores in Patients With Advanced Malignant Pleural Mesothelioma Treated in a Real-World Setting.

    Jto Clinical And Research Reports . 6(6): 100802-100802.

    [doi:10.1016/j.jtocrr.2025.100802]

  • García-Pardo M, García de Herreros M, Laguna JC, Gorría T, Lage Y, Gómez A, Olmedo ME, Garrido P, Albarran-Artahona VM, Arcocha A, Teixido C, Reguart N, Navarro A, Auclin E, Nahorski MS, Howarth K, Planchard D, Besse B, Leighl NB, Mezquita L.

    Brief Report: Real-World Clinical Utility of Next-Generation Sequencing of Circulating Tumor DNA for Patients With Advanced Lung Squamous Cell Carcinoma (SQUIN).

    CLINICAL LUNG CANCER . 26(4): .

    [doi:10.1016/j.cllc.2025.02.007]

  • Chiang AC, Olmedo Garcia ME, Carlisle JW, Dowlati A, Reguart N, Felip E, Jost PJ, Steeghs N, Stec R, Gadgeel SM, Loong HH, Jiang W, Hamidi A, Parkes A, Paz-Ares L.

    Safety of tarlatamab with 6-8-h outpatient versus 48-h inpatient monitoring during cycle 1: DeLLphi-300 phase 1 substudy.

    ESMO open . 10(4): 104538-104538.

    [doi:10.1016/j.esmoop.2025.104538]

  • Sereno M, Collazo-Lorduy A, Garitaonaindia Y, Gómez de Antonio D, Baena Espinar J, Aguado de la Rosa C, Cruz Castellanos P, Falagán Martínez S, Chara Valverde LE, López-Castro R, López-Martin A, Rubio-Pérez J, Gómez Rueda A, Traseira Puchol C, Mielgo Rubio X, Losada Vila B, Rogado J, Bernal Hertfelder E, Gutiérrez Sainz L, Campo-Cañaveral JL, Romano I, Thuissard I, Rubio Romero G, Casado Sáenz E.

    Analysis of operability parameter changes in neoadjuvant treatment with chemotherapy and anti-PD-1/PD-L1.

    Cancer Treatment and Research Communications . 43: 100910-100910.

    [doi:10.1016/j.ctarc.2025.100910]

  • Solomon BJ, Tan DSW, de Castro G Jr, Cobo M, Garassino MC, Zhang J, Johnson BE, Lee JM, Garrido P, Butler AA, Pelletier MR, Savchenko A, Ji L, Brase JC, Caparica R, Demanse D, Wu J, Bossen C, Mok T.

    The Impact of the Tumor Microenvironment on the Effect of IL-1ß Blockade in NSCLC: Biomarker Analyses from CANOPY-1 and CANOPY-N Trials.

    Cancer Research Communications . 5(4): 632-646.

    [doi:10.1158/2767-9764.CRC-24-0490]

  • García-Latorre R, Gorospe L, González-Huete A.

    Right extrapleural hematoma due to thoracic trauma. The extrapleural fat sign.

    JORNAL BRASILEIRO DE PNEUMOLOGIA . 51(1): .

    [doi:10.36416/1806-3756/e20250027]

  • Gorospe L, Arrieta P, Barbolla-Díaz I, Mirambeaux-Villalona RM, Montelongo-Martín A.

    Bronchial anthracofibrosis beyond bronchial involvement causing pulmonary artery stenosis.

    LUNG INDIA . 42(2): 161-162.

    [doi:10.4103/lungindia.lungindia_99_24]

  • Salgado-Parente A, deVicente AG, Alarcón-Rodríguez J, Rivero Jiménez N.

    Cervical aortic arch: a rare congenital anomaly.

    Anales De Pediatria . 102(1): 503697-503697.

    [doi:10.1016/j.anpede.2024.503697]

  • Trujillo JC, Soriano JB, Marzo M, Higuera O, Gorospe L, Pajares V, Olmedo ME, Arrabal N, Flores A, García JF, Crespo M, Carcedo Rodriguez D, Heuser C, Obradovic MM, Olghi N, Choman EN, Seijo LM.

    Cost-effectiveness of a machine learning risk prediction model (LungFlag(TM)) in the selection of high-risk individuals for non-small cell lung cancer screening in Spain.

    Journal of medical economics . : 1-16.

    [doi:10.1080/13696998.2024.2444781]

  • Cortés-Salgado A, Serrano JJ, Cordero Pereda D, Menacho M, del Rey JM, Del Campo-Albendea L, Saavedra C, Chamorro J, Rosero D, Sotoca P, Guillén-Ponce C, Guerra E, Fernández-Abad M, López-Miranda E, Martínez-Jáñez N, Gion M, Salazar MT, Agudo-Quílez P, Garrido P, Alonso Salinas GL.

    Anthracyclines-induced cardiotoxicity in patients with early breast cancer carrying germline BRCA1/2 mutation: the BRCAN study.

    ONCOLOGIST . : .

    [doi:10.1093/oncolo/oyae299]

  • Villanueva Campos A, Canales Lachén E, Suevos Ballesteros C, Alarcón Rodríguez J.

    Multi-energy CT and iodinated contrast.

    Radiologia . 66 Suppl 2: .

    [doi:10.1016/j.rxeng.2024.03.011]